Skip to main content

Want a detailed portfolio tracker?

Immunome (IMNM) P/E (2021 - 2026)

Immunome (IMNM) P/E from Mar 31, 2021 to Jun 3, 2026. The TTM Immunome (IMNM) P/E is -8.93. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Immunome (IMNM)

YearP/EChange
2026-8.93-7.64%
2025-9.67+336.51%
2024-2.21-93.78%
2023-35.58+718.04%
2022-4.35-88.27%
2021-37.09N/A

Comparison Immunome (IMNM) P/E with competitors

Immunome (IMNM) P/E is -8.93.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-101.14%
ENLVEnlivex Therapeutics Ltd0.15-101.68%
FGENFibroGen Inc0.24-102.69%
TRAWTraws Pharma Inc0.47-105.30%
FBIOFortress Biotech Inc0.71-107.91%
CHRSCoherus Biosciences Inc0.98-110.96%
ORMPOramed Pharmaceuticals Inc1.47-116.50%
AGENAgenus Inc2.05-122.94%
VIVSVivoSim Labs Inc2.54-128.40%
INVAInnoviva Inc3.19-135.71%
CRMDCorMedix Inc3.65-140.83%
ABEOAbeona Therapeutics Inc4.20-147.10%
VXRTVaxart Inc4.26-147.73%
CVACCureVac N.V.4.45-149.79%
SRPTSarepta Therapeutics Inc4.62-151.79%
GLPGGalapagos NV4.86-154.42%
RIGLRigel Pharmaceuticals4.92-155.10%
ZVRAZevra Therapeutics Inc4.97-155.71%
ABUSArbutus Biopharma Corp5.69-163.77%
CGENCompugen Ltd7.38-182.71%
AUPHAurinia Pharmaceuticals Inc9.25-203.62%
ACADAcadia Pharmaceuticals Inc9.59-207.39%
OMEROmeros Corporation9.88-210.70%
PLXProtalix BioTherapeutics Inc9.91-210.99%
SPROSpero Therapeutics Inc10.73-220.24%
ADMAAdma Biologics Inc11.33-226.91%
SVASinovac Biotech Ltd11.44-228.09%
TBPHTheravance Biopharma Inc11.78-231.91%
HRMYHarmony Biosciences Holdings Inc12.18-236.43%
TGTXTG Therapeutics Inc13.18-247.62%
INCYIncyte Corp13.38-249.89%
SABSSAB Biotherapeutics Inc14.06-257.46%
XOMAXOMA Corp14.95-267.40%
REGNRegeneron Pharmaceuticals Inc14.98-267.79%
PBYIPuma Biotechnology Inc15.05-268.58%
EXELExelixis Inc15.79-276.92%
NAGENiagen Bioscience Inc16.35-283.19%
CPRXCatalyst Pharmaceuticals Inc17.34-294.28%
MDXGMimedx Group Inc17.38-294.62%
ARGXArgen X SE23.07-358.42%
HALOHalozyme Therapeutics Inc23.20-359.87%
XOMAOXOMA Corp25.34-383.89%
VRTXVertex Pharmaceuticals Inc25.66-387.37%
XOMAPXOMA Corp25.67-387.53%
CTMXCytomX Therapeutics Inc25.70-387.84%
ASNDAscendis Pharma A/S26.35-395.19%
RPRXRoyalty Pharma plc - Class A27.50-407.98%
SLNOSoleno Therapeutics Inc29.02-425.00%
LGNDLigand Pharmaceuticals Inc - Class B30.19-438.12%
BMRNBiomarin Pharmaceutical Inc37.51-520.12%
APLSApellis Pharmaceuticals Inc39.02-537.08%
KRYSKrystal Biotech Inc39.70-544.65%
GMABGenmab40.20-550.32%
ONCBeiGene Ltd67.03-850.77%
TECHBio-Techne Corp68.59-868.33%
VCELVericel Corp80.63-1003.13%
PHARPharming Group N.V.87.74-1082.78%
ALNYAlnylam Pharmaceuticals Inc124.93-1499.38%
TLXTelix Pharmaceuticals Ltd139.89-1666.92%
CORTCorcept Therapeutics Inc158.39-1874.12%